^
No biomarker
Rectal Cancer
FOLFIRI
Sensitive
:
A1
No biomarker
Rectal Cancer
Mvasi (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Rectal Cancer
irinotecan
Sensitive
:
A1
No biomarker
Rectal Cancer
Bevax (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Rectal Cancer
FOLFOXIRI
Resistant
:
A2
No biomarker
Rectal Cancer
capecitabine
Sensitive
:
A2
No biomarker
Rectal Cancer
FOLFOX
Sensitive
:
A2
MSI-H/dMMR
Rectal Cancer
nivolumab
Sensitive
:
C1
PD-L1 expression
Rectal Cancer
nivolumab
Sensitive
:
C3
TMB-H
Rectal Cancer
nivolumab
Sensitive
:
C3
TACC3 expression
Rectal Cancer
5-fluorouracil
Resistant
:
C3
TACC3 expression
Rectal Cancer
FOLFOX
Resistant
:
C3
TACC3 expression
Rectal Cancer
CAPOX
Resistant
:
C3
TACC3 expression
Rectal Cancer
capecitabine
Resistant
:
C3
PAI1 expression
Rectal Cancer
AZD1208
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our